FDA authorizes Pfizer COVID booster for children 5-11

By Axios
| May 17, 2022

The Food and Drug Administration on Tuesday authorized booster doses of the Pfizer-BioNTech coronavirus vaccine for children between the ages of 5 and 11.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...